+13.01% for Injective as buyers remain in control above $6 milestone
Injective (INJ) is trading at $6.16, advancing 13.01% on the day and holding well above its key moving averages. This positions the asset firmly in upward territory relative to major trend metrics.
Highlights
- INJ is in a strong bullish trend, trading well above major moving average and Ichimoku support levels.
- Momentum indicators are firmly bullish, but overbought signals suggest potential for short-term consolidation or reversal risk.
- Price is expected to range between $5.71 and $6.20 over the next week, with a breakout above $6.20 triggering further upside.
Momentum strength capped by overbought risk as price tops support band
INJ’s technical profile on the daily timeframe shows the current price at $6.16, notably above the MA-20 at $5.02, MA-50 at $4.07, and MA-200 at $4.25. The Ichimoku Kijun level at $4.89 serves as immediate support, with the price comfortably clear of this threshold. RSI records 64.20, indicating elevated momentum but bordering on overbought conditions, while the Stochastic RSI and CCI also register strong buying signals. The MACD maintains a strong bullish configuration and the ADX is high, demonstrating robust trend strength. Bull/Bear Power (BBP) remains positive, reflecting continued intraday buyer dominance, and the price has stayed near the session’s highs ($5.47–$6.09) throughout. However, the Awesome Oscillator (AO) is neutral, adding a modest note of caution.
Balanced price scenarios as volatility anchors INJ to established range
For the near term, INJ is likely to experience typical volatility within a band of $5.71 to $6.20 over the next five trading days. Price scenarios are balanced, with a sideways movement near current levels as the base case. A break above $6.20 would open the door for renewed upside momentum beyond recent highs, while a move under $5.71 could trigger a deeper retracement toward support levels defined by the Ichimoku Kijun and underlying moving averages.
Earlier, analysts noted that Injective was maintaining strong bullish momentum across multiple timeframes despite intermittent technical uncertainties. The current analysis reinforces this outlook with fresh signals of trend strength and buying pressure, suggesting that traders should monitor for a decisive move above $6.20 as the next potential catalyst for further upside.
Latest Injective News
- Forex
- Crypto